Sort
48,018 grants matching “immunotherapy”
Antibody Engineering Program
$588,522Mitchell Ho · Division Of Basic Sciences - Nci · ZIC · FY2022 · CA
EASTERN COOPERATIVE ONCOLOGY GROUP - WISCONSIN STUDIES
$588,460James A Stewart · University Of Wisconsin-Madison · U10 · FY2007 · CA
HBV-specific T cell immunity in HBV/HIV coinfection
$588,450Michael Jeffrey Vinikoor · University Of Alabama At Birmingham · R37 · FY2025 · AI
Pan-Cancer characterization of 3âUTR somatic mutations controlling tumor immune evasion
$588,394Ioannis Vlachos · Beth Israel Deaconess Medical Center · R01 · FY2025 · CA
Embryonic natural killer cell development and function
$588,284Christopher Michael Sturgeon · Icahn School Of Medicine At Mount Sinai · R01 · FY2022 · HL
Micro-nanotechnologies for the analysis of islet-derived extracellular vesicles implicated in Type 1 Diabetes
$588,253Alphonsus Ng · Utah State Higher Education System--University Of Utah · R01 · FY2025 · DK
PD-1/PD-L1 modulation in cancer therapy
$588,135Drew M. Pardoll · Johns Hopkins University · R01 · FY2022 · CA
Regulation of anti-tumor immunity by HDAC11
$588,117Edward Seto · George Washington University · R01 · FY2021 · CA
Novel Approaches Targeting B7-H3 in Castration-resistant Prostate Cancer
$588,065Di Zhao · University Of Tx Md Anderson Can Ctr · R01 · FY2025 · CA
Novel Approaches Targeting B7-H3 in Castration-resistant Prostate Cancer
$588,065Di Zhao · University Of Tx Md Anderson Can Ctr · R01 · FY2023 · CA
Targeting the host immune response during sepsis
$587,877Guochang Hu · University Of Illinois At Chicago · R01 · FY2022 · HL
Targeting the host immune response during sepsis
$587,877Guochang Hu · University Of Illinois At Chicago · R01 · FY2021 · HL
Immune cell control of ovarian cancer
$587,759Christina Annunziata · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Advancing the translatability of mouse models for cancer immunotherapy
$587,737Rosemary J Akhurst · University Of California, San Francisco · R01 · FY2018 · CA
Targeting Aldehyde Dehydrogenase for Cancer Prevention
$587,645Gavin P. Robertson · Pennsylvania State Univ Hershey Med Ctr · R01 · FY2023 · CA
Non-invasive imaging of the anti-tumor immune response
$587,640Novalia Pishesha · Boston Children'S Hospital · R01 · FY2025 · CA
Proj 3 - Targeting the Pro-tumorigenic Microenvironment
$587,566Yves A Declerck · Children'S Hosp Of Philadelphia · P01 · FY2020 · CA
Suppressing the Co-chaperone UNC45A reprograms the immunosuppressive tumor microenvironment to fight Cancer
$587,524Ahmed Chadli · Augusta University · R01 · FY2025 · CA
Body composition and the obesity paradox in clear cell renal cell carcinoma
$587,431Anna Helena Furberg-Barnes · Sloan-Kettering Inst Can Research · R01 · FY2023 · CA
Data-driven inference of regulators for cytokine-mediated tumor killing
$587,416Peng Jiang · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
Using the IL-1R1 and its ligands to optimize the T cell immune response to cancer
$587,394Thomas S. Kupper · Brigham And Women'S Hospital · R01 · FY2024 · CA
EASTERN COOPERATIVE ONCOLOGY GROUP--WISCONSIN STUDIES
$587,298University Of Wisconsin Madison · U10 · FY2001 · CA
Understanding how metabolic heterogeneity in cancer affects the tumor microenvironment and anti-tumor immunity
$587,283Susan M Kaech · Salk Institute For Biological Studies · R01 · FY2022 · CA
Understanding how metabolic heterogeneity in cancer affects the tumor microenvironment and anti-tumor immunity
$587,283Susan M Kaech · Salk Institute For Biological Studies · R01 · FY2023 · CA
Characterizing the sources, mechanisms, and translational relevance of microbial TMAO in driving anti-tumor immunity in pancreatic cancer.
$587,277Rahul Suresh Shinde · Wistar Institute · R37 · FY2024 · CA